42/100

Emerging evidence

Cite
More
EmailLinkedInX

Red Queen Bio is using AI to design antibodies for future viruses, WSJ says

Evidence type
News report
Sources
1 sourceJournalism
Published
1 min read

OpenAI-backed Red Queen Bio uses AI to design antibodies against bird flu and future viruses, the WSJ reports. It has raised $36M in total.

Red Queen Bio is using AI to design antibodies for future viruses, WSJ says

The gain

AI is being used to design antibodies intended to target bird flu and other future viruses.

In brief

On September 28, 2026, TNW reported on WSJ coverage of Red Queen Bio, an OpenAI-backed company that uses AI to design antibodies against bird flu and future viruses, and that has raised $36M in total.

The development matters for pandemic preparedness because AI-designed antibodies could accelerate response to emerging threats, but the source provides no evidence of efficacy, safety testing, or deployment, leaving real-world impact unproven at the time of reporting.

Main points

  1. Red Queen Bio is described as OpenAI-backed.
  2. The company's stated application is designing antibodies against bird flu and future viruses.
  3. The information is attributed to WSJ reporting, summarized by TNW.
  4. The company has raised $36M in total according to the report.

The full story

TNW summarized WSJ reporting on September 28, 2026 that Red Queen Bio is OpenAI-backed and focused on AI-designed antibodies.

The brief report also notes financing, stating the company has raised $36M in total, but provides no technical details, timelines, or clinical validation data.

Sources

1 on file
  1. TNWthenextweb.com
    Journalism2026-09-28

Talk it over

What readers make of this record

What readers say